Paris: The FDA has approved UZEDY, the first subcutaneous long-acting risperidone formulation utilizing SteadyTeq™ technology ...

On World Mental Health Day, this writer narrates her story of struggling with bipolar disorder, an illness that has ...

FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive ...

YouTube has become a favorite platform for many people with mental health problems. It is a place where they can share their ...

This is a developing news story. Please check back soon for updates. The FDA approved extended-release Uzedy for the ...

Living with bipolar disorder isn’t just about mood swings: It’s about carrying an invisible weight that few people understand. For high-achieving women like me, that weight becomes even heavier. We’re ...

A WIRRAL author is shining a new light on mental health. In Bipolar & I: Dancing with Darkness, Flirting with Fabulous, ...

Teva Pharmaceutical Industries (NYSE:TEVA) just landed U.S. FDA approval for UZEDY, an extended-release injectable developed ...

Mood tracking can be an effective tool for managing and preventing bipolar disorder episodes. Here’s how it works. Living with bipolar disorder can be overwhelming at times. The shifts between ...

There is a lot of confusion about what bipolar disorder is, despite the fact that approximately 2.6% of the population is diagnosed with the condition. To anyone on the outside, they may have very ...

What if the very thing that destroyed your closest relationship eventually became the bridge that rebuilt it? For Gabrielle ...

The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I ...